Curis CRIS
NASDAQ CRIS
$1.58 -0.03 (-1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Curis (CRIS) Other financing activities (2014 - 2023)

Curis' (CRIS) quarterly Other financing activities came in at $178000.0 in Q2 2023, up 19.46% YoY from $149000.0 in Q2 2022, and up 2442.86% on a QoQ basis from $7000.0 in Q1 2023.

Curis (CRIS) Other financing activities (2014 - 2023) Analysis & Trends

Curis (CRIS) has 10 years of Other financing activities data on file, last reported at $178000.0 in Q2 2023.

  • Quarterly Other financing activities rose 19.46% year-over-year to $178000.0 in Q2 2023, while the trailing twelve-month figure through Sep 2023 was $284000.0 (up 22.41% YoY) and the FY2022 annual result came in at $248000.0, down 17.33% from the prior year.
  • Other financing activities rose to $178000.0 in Q2 2023, from $7000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $169.6 million in Q4 2020 to a low of $7000.0 in Q1 2023.
  • A 5-year average of $17.1 million and a median of $99000.0 in 2022 frame the typical range for Other financing activities.
  • Annual changes were most pronounced in 2020 — Other financing activities soared 652207.69% — and 2021, when it plunged 99.95%.
  • Tracing CRIS's Other financing activities over 5 years: stood at $26000.0 in 2019, then soared by 652207.69% to $169.6 million in 2020, then sank by 99.95% to $83000.0 in 2021, then climbed by 19.28% to $99000.0 in 2022, then surged by 79.8% to $178000.0 in 2023.
  • The last three Other financing activities figures came in at $178000.0 (Q2 2023), $7000.0 (Q1 2023), and $99000.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Curis 3.27 Mn -2.35 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 178,000.00
Jun 30, 2023 178,000.00
Mar 31, 2023 7,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 99,000.00
Dec 31, 2022 99,000.00
Jun 30, 2022 149,000.00
Jun 30, 2022 149,000.00
Dec 31, 2021 83,000.00
Dec 31, 2021 83,000.00
Sep 30, 2021 22,000.00
Sep 30, 2021 22,000.00
Jun 30, 2021 116,000.00
Jun 30, 2021 116,000.00
Mar 31, 2021 79,000.00
Mar 31, 2021 79,000.00
Dec 31, 2020 169.60 Mn
Dec 31, 2020 169.60 Mn
Jun 30, 2020 17.50 Mn
Jun 30, 2020 17.50 Mn